X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SUN PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SUN PHARMA ABBOTT INDIA/
SUN PHARMA
 
P/E (TTM) x 34.9 25.8 135.6% View Chart
P/BV x 9.0 2.7 332.3% View Chart
Dividend Yield % 0.8 0.5 164.5%  

Financials

 ABBOTT INDIA   SUN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
SUN PHARMA
Mar-18
ABBOTT INDIA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs6,110701 872.2%   
Low Rs3,996433 922.4%   
Sales per share (Unadj.) Rs1,552.2110.4 1,405.9%  
Earnings per share (Unadj.) Rs188.811.0 1,719.9%  
Cash flow per share (Unadj.) Rs196.417.2 1,140.1%  
Dividends per share (Unadj.) Rs55.002.00 2,750.0%  
Dividend yield (eoy) %1.10.4 308.5%  
Book value per share (Unadj.) Rs796.6158.8 501.6%  
Shares outstanding (eoy) m21.252,399.26 0.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.35.1 63.4%   
Avg P/E ratio x26.851.6 51.8%  
P/CF ratio (eoy) x25.732.9 78.2%  
Price / Book Value ratio x6.33.6 177.7%  
Dividend payout %29.118.2 159.9%   
Avg Mkt Cap Rs m107,3761,360,021 7.9%   
No. of employees `0003.317.8 18.7%   
Total wages/salary Rs m3,93753,671 7.3%   
Avg. sales/employee Rs Th9,929.314,890.9 66.7%   
Avg. wages/employee Rs Th1,185.13,017.1 39.3%   
Avg. net profit/employee Rs Th1,207.71,480.6 81.6%   
INCOME DATA
Net Sales Rs m32,985264,895 12.5%  
Other income Rs m1,1708,388 13.9%   
Total revenues Rs m34,155273,282 12.5%   
Gross profit Rs m5,24556,081 9.4%  
Depreciation Rs m16214,998 1.1%   
Interest Rs m385,176 0.7%   
Profit before tax Rs m6,21544,295 14.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-9,505 0.0%   
Tax Rs m2,2038,452 26.1%   
Profit after tax Rs m4,01226,338 15.2%  
Gross profit margin %15.921.2 75.1%  
Effective tax rate %35.419.1 185.7%   
Net profit margin %12.29.9 122.3%  
BALANCE SHEET DATA
Current assets Rs m22,655316,359 7.2%   
Current liabilities Rs m6,681198,643 3.4%   
Net working cap to sales %48.444.4 109.0%  
Current ratio x3.41.6 212.9%  
Inventory Days Days6595 68.3%  
Debtors Days Days29108 27.1%  
Net fixed assets Rs m835213,178 0.4%   
Share capital Rs m2132,399 8.9%   
"Free" reserves Rs m16,715378,606 4.4%   
Net worth Rs m16,928381,006 4.4%   
Long term debt Rs m017,721 0.0%   
Total assets Rs m24,162643,028 3.8%  
Interest coverage x163.79.6 1,712.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.4 331.4%   
Return on assets %16.84.9 342.0%  
Return on equity %23.76.9 342.9%  
Return on capital %36.910.0 368.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36940,816 0.9%   
Fx outflow Rs m3,80730,143 12.6%   
Net fx Rs m-3,43810,673 -32.2%   
CASH FLOW
From Operations Rs m1,52739,072 3.9%  
From Investments Rs m-2,148-33,708 6.4%  
From Financial Activity Rs m-1,024-15,393 6.7%  
Net Cashflow Rs m-1,646-7,359 22.4%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 5.1 154.0%  
FIIs % 0.1 23.0 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 8.3 206.0%  
Shareholders   18,270 133,026 13.7%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  MERCK LTD  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 142 Points Higher; Metal and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended the day on a positive note. Gains were largely seen in the metal sector and healthcare sector.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 21, 2019 03:35 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS